Metobeta

Metoprolol Tartrate, the active ingredient in Metobeta, is a beta blocker presented as an oral tablet for oral use. It treats hypertension, angina pectoris, post‑myocardial infarction and chronic heart failure in adult patients.

GNH USA supplies Metobeta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metobeta is a selective β1‑adrenergic blocker used in cardiovascular conditions where reduction of heart rate and myocardial workload is required. - Hypertension: lowers systolic and diastolic pressure by decreasing cardiac output. - Angina pectoris: reduces myocardial oxygen demand, relieving chest pain during exertion. - Post‑myocardial infarction: improves survival by limiting arrhythmias and remodeling. - Chronic heart failure: enhances ventricular function and decreases hospitalization risk.

Metobeta may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headed sensation, especially on standing. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea, abdominal discomfort. - Sleep disturbances: insomnia or vivid dreams.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to fainting. - Bronchospasm in patients with reactive airway disease. - Allergic reactions such as rash, itching, or angioedema. - Depression or mood changes. - Worsening heart failure symptoms.

When prescribing Metobeta, clinicians should consider several safety measures. - Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess heart rate: ensure rate remains within therapeutic range. - Use caution in asthma or COPD: β1‑selectivity may not fully prevent bronchoconstriction. - Avoid abrupt discontinuation: taper dose to prevent rebound tachycardia. - Adjust dose in renal impairment: reduced clearance may increase drug exposure. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Metobeta can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): may cause severe heart block. - Clonidine: abrupt withdrawal can precipitate hypertensive crisis.

Moderate Interactions (Monitor Closely): - Diuretics: risk of excessive blood pressure reduction. - ACE inhibitors or ARBs: potential for marked hypotension. - Antidepressants (SSRIs, SNRIs): may increase bradycardia risk. - NSAIDs: can blunt antihypertensive effect.